Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 6, 2025
Metabolic profiles of the human blood-brain barrier cells treated by TNF-alpha and oxysterolsCindy Nguyen, Kenneth C P Cheung, Xiaoli Chen, et al.
Systematic Reviews|December 8, 2023
Quality of reporting of integrative Chinese and Western medicine intervention in randomized controlled trials of ulcerative colitis: a reviewJialing Zhang, Jiashuai Deng, Nana Wang, et al.
Carbohydrate Polymers|August 8, 2021
Cordyceps polysaccharide marker CCP modulates immune responses via highly selective TLR4/MyD88/p38 axisQuanwei Zhang, Man Liu, Lifeng Li, et al.
International Journal of Biological Macromolecules|July 9, 2026
Dynamic distribution of label-free polysaccharides after intestinal lymphatic absorptionWenting Zhao, Xueting Zhang, Pengfei Shan, et al.
The American Journal of Chinese Medicine|September 10, 2020
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)Xuan Zhang, Ran Tan, Wai Ching Lam, et al.
Frontiers in Pharmacology|March 11, 2024
Evaluation of compliance of CONSORT-CHM formula 2017 in randomized controlled trials of Chinese herbal medicine formulas: protocol of a five-year reviewJuan Wang, Chung Wah Cheng, Yalin Jiao, et al.
Frontiers in Neurology|August 5, 2024
The use of acupuncture for addressing neurological and neuropsychiatric symptoms in patients with long COVID: a systematic review and meta-analysisWai Ching Lam, Dongjue Wei, Huijuan Li, et al.
Journal of Evidence-Based Medicine|March 15, 2023
STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT statementXuan Zhang, Feng Liang, Chung Tai Lau, et al.
Frontiers of Medicine|August 8, 2024
Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicineXuan Zhang, Han Li, Hanzhi Tan, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophyShanshan Yao, Xin Yang, Meishen Ren, et al.
Pageof 9